USAID Announces $12 Mln Cancer Prevention Fund For Sub Saharan Africa

THE United States Agency for International Development (USAID), in partnership with the U.S. National Academies of Science, Engineering, and Medicine, will dedicate $12 million to support the expansion of programs, to prevent cervical cancer in the Republics of Malawi and Mozambique through integrated programs to improve women’s health. Cervical cancer is an outcome of infection with the human papillomavirus (HPV). To reduce cervical cancer in Malawi and Mozambique, USAID will fund activities through the following partnerships: accelerating the introduction of a screen-and-treat strategy for HPV and cervical pre-cancerous lesions in…

Share
Read More

DRC: MSF starts enrolling patients in clinical trial of potential Ebola treatments

THE Ebola Treatment Centres operated by Doctors Without Borders (MSF) in Katwa and Butembo, in collaboration with the Ministry of Health, are participating in a randomized controlled trial (RCT) of four potential Ebola-treatments in North Kivu, Democratic Republic of Congo (DRC). The trial originally began in November in another treatment centre in the region and MSF facilities are now in a position to contribute to providing valuable information on these developmental products. The treatments that will be used in the RCT are Remdesivir, mAb114, REGN-EB3 and ZMapp. They have been…

Share
Read More